...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
Reply New Message
Back To Forum List View
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
2
coldnewfie
May 19, 2024 08:42AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
narmac
May 19, 2024 08:53PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
3
chicagoest
May 19, 2024 10:21PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
KOO-KOO2
May 20, 2024 01:50PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
2
chicagoest
May 20, 2024 02:03PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
KOO-KOO2
May 20, 2024 03:33PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
narmac
May 20, 2024 08:30PM

Koo -

clinical trials.gov #
NCT03901469

i errored earlier - this is trial 5 of the 19 listed under Zen3694

Chicagoest

1 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply